Key Recent Advances in Atherosclerosis Treatment With Modern Lipid-Lowering Drugs: The New Frontier With PCSK9 Inhibitors
European Cardiology Review - United Kingdom
doi 10.15420/ecr.2017.12.1.ge3
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Radcliffe Group Ltd